Christopher M. Jewell

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Christopher Jewell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher M. Jewell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Chief Scientific Officer Common Stock 62,490 $201,843 $3.23 10 Jan 2025 Direct
Cartesian Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 67,432 $53,271 $0.7900 10 Jan 2025 Direct
Cartesian Therapeutics, Inc. Chief Scientific Officer Employee Stock Option (right to buy) 47,400 02 Jan 2025 Direct

Insider Reports Filed by Christopher M. Jewell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAC Cartesian Therapeutics, Inc. 10 Jan 2025 2 +$29,070 4 Chief Scientific Officer 13 Jan 2025, 16:09
RNAC Cartesian Therapeutics, Inc. 03 Jan 2025 2 -$42,783 4 Chief Scientific Officer 07 Jan 2025, 20:05
RNAC Cartesian Therapeutics, Inc. 02 Jan 2025 2 $0 4 Chief Scientific Officer 06 Jan 2025, 16:21
RNAC Cartesian Therapeutics, Inc. 20 Nov 2024 2 +$45,220 4 Chief Scientific Officer 21 Nov 2024, 18:50
RNAC Cartesian Therapeutics, Inc. 14 Nov 2024 7 -$706,711 4 Chief Scientific Officer 18 Nov 2024, 19:23
RNAC Cartesian Therapeutics, Inc. 08 Apr 2024 2 $0 4 Chief Scientific Officer 10 Apr 2024, 21:35
RNAC Cartesian Therapeutics, Inc. 02 Jan 2024 2 $0 4 Chief Scientific Officer 04 Jan 2024, 17:08
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 1 $0 4 Chief Scientific Officer 15 Nov 2023, 16:42
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 0 $0 3 Chief Scientific Officer 15 Nov 2023, 16:38